Mindray Medical International Limited is a developer, manufacturer and marketer of medical devices across the world. The Company operates in three segments: patient monitoring and life support products, in-vitro diagnostic products and medical imaging systems. Its patient monitoring devices track the physiological parameters of patients, such as heart rate, blood pressure, respiration and temperature. It offers patient monitoring devices that are suitable for adult, pediatric and neonatal patients and are used principally in hospital intensive care units, operating rooms and emergency rooms. Its life support products provide operation room or intensive care unit solutions for the end users in the operating room. Its in-vitro diagnostic products provide data and analysis on blood, urine and other bodily fluid samples for clinical diagnosis and treatment. Its medical imaging systems segment includes ultrasound systems, digital radiography systems and a magnetic resonance imaging system.
Industry, Sector and Symbol:
- Sector: Healthcare
- Industry: Medical Instruments & Supplies
- Sub-Industry: N/A
- Symbol: NYSE:MR
- CUSIP: N/A
- Web: N/A
- 50 Day Moving Avg: $27.20
- 200 Day Moving Avg: $25.81
- 52 Week Range: $21.80 - $33.83
- Trailing P/E Ratio: N/A
- Foreward P/E Ratio: 15.97
- P/E Growth: 0.00
- Average Volume: 965,593 shs.
Frequently Asked Questions for Mindray Medical International Ltd (NYSE:MR)
What is Mindray Medical International Ltd's stock symbol?
Mindray Medical International Ltd trades on the New York Stock Exchange (NYSE) under the ticker symbol "MR."
How were Mindray Medical International Ltd's earnings last quarter?
Mindray Medical International Ltd (NYSE:MR) announced its earnings results on Friday, November, 13th. The company reported $0.51 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of $0.32 by $0.19. The business had revenue of $327.60 million for the quarter. During the same quarter in the prior year, the company earned $0.47 earnings per share. View Mindray Medical International Ltd's Earnings History.
Who are some of Mindray Medical International Ltd's key competitors?
Some companies that are related to Mindray Medical International Ltd include Becton Dickinson and Co (BDX), Baxter International (BAX), C R Bard (BCR), Mettler-Toledo International (MTD), DENTSPLY SIRONA (XRAY), Waters (WAT), Cooper Companies (COO), Teleflex Incorporated (TFX), West Pharmaceutical Services (WST), Hill-Rom Holdings (HRC), Integra Lifesciences Holdings Corp (IART), ICU Medical, Incorporated (ICUI), ProShares UltraShort DJ-UBS Commodity (CMD), Insulet (PODD), Haemonetics (HAE), Inogen (INGN), Merit Medical Systems (MMSI) and Halyard Health (HYH).
How do I buy Mindray Medical International Ltd stock?
Shares of Mindray Medical International Ltd can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How much does a share of Mindray Medical International Ltd stock cost?
One share of Mindray Medical International Ltd stock can currently be purchased for approximately $27.94.
Earnings History for Mindray Medical International Ltd (NYSE:MR)Earnings History by Quarter for Mindray Medical International Ltd (NYSE:MR)
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|8/10/2015||Q215||$0.43||$0.42||$360.50 million||$336.80 million||View||Listen|
|5/11/2015||Q1||$0.38||$0.33||$288.50 million||$272.50 million||View||Listen|
|3/9/2015||Q4||$0.52||$0.50||$407.07 million||$399.00 million||View||Listen|
|11/3/2014||Q314||$0.43||$0.43||$334.50 million||$324.60 million||View||Listen|
|5/5/2014||Q114||$0.37||$0.50||$292.50 million||$264.80 million||View||Listen|
|3/3/2014||Q413||$0.50||$0.62||$351.26 million||$368.40 million||View||Listen|
|8/5/2013||Q2 2013||$0.47||$0.56||$312.06 million||$307.20 million||View||Listen|
|5/6/2013||Q1 2013||$0.41||$0.53||$254.97 million||$242.10 million||View||Listen|
|2/25/2013||Q4 2012||$0.39||$0.51||$309.30 million||$316.10 million||View||Listen|
|11/5/2012||Q312||$0.41||$0.42||$260.02 million||$257.10 million||View||N/A|
Earnings Estimates for Mindray Medical International Ltd (NYSE:MR)
Current Year EPS Consensus Estimate: $1.54 EPS
Next Year EPS Consensus Estimate: $1.75 EPS
Current Dividend Information for Mindray Medical International Ltd (NYSE:MR)
|Most Recent Dividend:||3/31/2015|
|Dividend Growth:||0.00% (3 Year Average)|
|Payout Ratio:||0.00% (Based on This Year's Estimates)|
0.00% (Based on Next Year's Estimates)
Dividend History by Quarter for Mindray Medical International Ltd (NYSE:MR)
(Data available from 1/1/2013 forward)
|Announced||Period||Amount||Yield||Ex-Dividend Date||Record Date||Payable Date|
Insider Trading History for Mindray Medical International Ltd (NYSE:MR)
No insider trades for this company have been tracked by MarketBeat.com
Headline Trends for Mindray Medical International Ltd (NYSE:MR)
Latest Headlines for Mindray Medical International Ltd (NYSE:MR)
Mindray Medical International Ltd (MR) Chart for Wednesday, May, 24, 2017